Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'APO2 ligand' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 22 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Mitsiades, N; Mitsiades, CS; Poulaki, V; Anderson, KC; Treon, SP
      Concepts in the use of TRAIL/Apo2L: an emerging biotherapy for myeloma andother neoplasias

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    2. Sarker, M; Ruiz-Ruiz, C; Lopez-Rivas, A
      Activation of protein kinase C inhibits TRAIL-induced caspases activation,mitochondrial events and apoptosis in a human leukemic T cell line

      CELL DEATH AND DIFFERENTIATION
    3. Nguyen, T; Zhang, XD; Hersey, P
      Relative resistance of fresh isolates of melanoma to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis

      CLINICAL CANCER RESEARCH
    4. de Almodovar, CR; Ruiz-Ruiz, C; Munoz-Pinedo, C; Robledo, GH; Lopez-Rivas, A
      The differential sensitivity of Bcl-2-overexpressing human breast tumor cells to TRAIL or doxorubicin-induced apoptosis is dependent on Bcl-2 proteinlevels

      ONCOGENE
    5. Rohn, TA; Wagenknecht, B; Roth, W; Naumann, U; Gulbins, E; Krammer, PH; Walczak, H; Weller, M
      CCNU-dependent potentiation of TRAIL/Apo2L-induced apoptosis in human glioma cells is p53-independent but may involve enhanced cytochrome c release

      ONCOGENE
    6. Oya, M; Ohtsubo, M; Takayanagi, A; Tachibana, M; Shimizu, N; Murai, M
      Constitutive activation of nuclear factor-kappa B prevents TRAIL-induced apoptosis in renal cancer cells

      ONCOGENE
    7. Wuchter, C; Krappmann, D; Cai, Z; Ruppert, V; Scheidereit, C; Dorken, B; Ludwig, WD; Karawajew, L
      In vitro susceptibility to TRAIL-induced apoptosis of acute leukemia cellsin the context of TRAIL receptor gene expression and constitutive NF-kappaB activity

      LEUKEMIA
    8. Baetu, TM; Kwon, H; Sharma, S; Grandvaux, N; Hiscott, J
      Disruption of NF-kappa B signaling reveals a novel role for NF-kappa B in the regulation of TNF-related apoptosis-inducing ligand expression

      JOURNAL OF IMMUNOLOGY
    9. Hilliard, B; Wilmen, A; Seidel, C; Liu, TST; Goke, R; Chen, YH
      Roles of TNF-related apoptosis-inducing ligand in experimental autoimmune encephalomyelitis

      JOURNAL OF IMMUNOLOGY
    10. Schempp, CM; Simon-Haarhaus, B; Termeer, CC; Simon, JC
      Hypericin photo-induced apoptosis involves the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and activation of caspase-8

      FEBS LETTERS
    11. Hao, CH; Beguinot, F; Condorelli, C; Trencia, A; Van Meir, EG; Yong, VW; Parney, IF; Roa, WH; Petruk, KC
      Induction and intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) mediated apotosis in human malignant gliomacells

      CANCER RESEARCH
    12. Zhang, XD; Zhang, XY; Gray, CP; Nguyen, T; Hersey, P
      Tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of human melanoma is regulated by Smac/DIABLO release from mitochondria

      CANCER RESEARCH
    13. Mitsiades, CS; Treon, SP; Mitsiades, N; Shima, Y; Richardson, P; Schlossman, R; Hideshima, T; Anderson, KC
      TRAIL/Apo2L ligand selectively induces apoptosis and overcomes drug resistance in multiple myeloma: therapeutic applications

      BLOOD
    14. Di Pietro, R; Secchiero, P; Rana, R; Gibellini, D; Visani, G; Bemis, K; Zamai, L; Miscia, S; Zauli, G
      Ionizing radiation sensitizes erythroleukemic cells but not normal erythroblasts to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated cytotoxicity by selective up-regulation of TRAIL-R1

      BLOOD
    15. Kim, KH; Fisher, MJ; Xu, SQ; El-Deiry, WS
      Molecular determinants of response to TRAIL in killing of normal and cancer cells

      CLINICAL CANCER RESEARCH
    16. Grotzer, MA; Eggert, A; Zuzak, TJ; Janss, AJ; Marwaha, S; Wiewrodt, BR; Ikegaki, N; Brodeur, GM; Phillips, PC
      Resistance to TRAIL-induced apoptosis in primitive neuroectodermal brain tumor cells correlates with a loss of caspase-8 expression

      ONCOGENE
    17. Monleon, I; Martiinez-Lorenzo, MJ; Anel, A; Lasierra, P; Larrad, L; Pineiro, A; Naval, J; Alava, MA
      CD59 cross-linking induces secretion of APO2 ligand in overactivated humanT cells

      EUROPEAN JOURNAL OF IMMUNOLOGY
    18. Sun, SY; Yue, P; Hong, WK; Lotan, R
      Augmentation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by the synthetic retinoid 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) through up-regulation of TRAIL receptors in human lung cancer cells

      CANCER RESEARCH
    19. Wang, QD; Ji, YS; Wang, XF; Evers, BM
      Isolation and molecular characterization of the 5 '-upstream region of thehuman TRAIL gene

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    20. Rieger, J; Ohgaki, H; Kleihues, P; Weller, M
      Human astrocytic brain tumors express AP02L/TRAIL

      ACTA NEUROPATHOLOGICA
    21. RIEGER J; NAUMANN U; GLASER T; ASHKENAZI A; WELLER M
      APO2 LIGAND - A NOVEL LETHAL WEAPON AGAINST MALIGNANT GLIOMA

      FEBS letters
    22. MARTINEZLORENZO MJ; ALAVA MA; GAMEN S; KIM KJ; CHUNTHARAPAI A; PINEIRO A; NAVAL J; ANEL A
      INVOLVEMENT OF APO2 LIGAND TRAIL IN ACTIVATION-INDUCED DEATH OF JURKAT AND HUMAN PERIPHERAL-BLOOD T-CELLS

      European Journal of Immunology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/10/20 alle ore 22:11:16